Skip to content

Clinical trials

Completed Multiple Sclerosis trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Status: Completed Country / region: Serbia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20075
20082
20095
20101
20111
20132
20143
20153
20161
20171
20182
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen7
Actelion4
Genzyme, a Sanofi Company4
Celgene2
EMD Serono Research & Development Institute, Inc.2
Merck KGaA, Darmstadt, Germany2
Teva Branded Pharmaceutical Products R&D, Inc.2
Eli Lilly and Company1
GeNeuro SA1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis29
Multiple Sclerosis, Relapsing-Remitting10
Recurrence6
Muscle Spasticity1
Sclerosis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.